Gain Therapeutics, Inc. (GANX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | -100% | - | - | -100% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | -100% | - | - | -100% |
| Operating Expenses | 5.35M | 4.47M | 4.79M | 5.09M | 4.37M | 3.33M | 4.46M | 8.18M | 4.38M | 4.41M | 4.89M | 7.73M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 2.59M | 2.12M | 1.94M | 2.33M | 2.11M | 2.11M | 1.84M | 3.75M | 1.87M | 2.03M | 2.52M | 3.74M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 2.76M | 2.35M | 2.85M | 2.76M | 2.26M | 1.22M | 2.62M | 4.44M | 2.51M | 2.37M | 2.37M | 3.99M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.35M | -4.47M | -4.79M | -5.09M | -4.37M | -3.33M | -4.46M | -8.18M | -4.38M | -4.41M | -4.89M | -7.73M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -22.52% | -34.07% | -7.33% | 37.8% | 0.19% | 24.42% | 8.72% | -5.84% | 16.29% | 3.38% | -2.82% | -49.35% |
| EBITDA | -5.33M | -4.44M | -4.76M | -5.07M | -4.35M | -3.31M | -4.44M | -8.16M | -4.36M | -4.38M | -4.86M | -7.71M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -22.62% | -34.08% | -7.34% | 37.92% | 0.19% | 24.5% | 8.78% | -5.85% | 16.38% | 3.51% | -2.77% | -49.54% |
| D&A (Non-Cash Add-back) | 21.3K | 28.24K | 22.82K | 22.33K | 20.66K | 21.31K | 21.64K | 20.59K | 20.53K | 23.59K | 20.51K | 20.24K |
| EBIT | -5.35M | -4.47M | -4.79M | -5.09M | -4.37M | -3.33M | -4.46M | -8.18M | -4.38M | -4.41M | -4.89M | -7.73M |
| Net Interest Income | 93.05K | 83.34K | 0 | 42.57K | 40.41K | 51.86K | 105.41K | 84.53K | 115.3K | 106.27K | 106K | 129.93K |
| Interest Income | 93.05K | 83.34K | 0 | 42.57K | 40.41K | 51.86K | 105.41K | 84.53K | 115.3K | 106.27K | 106K | 129.93K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -72.12K | -1.44K | 50.69K | -578.36K | -60.17K | 67.61K | -15.73K | 40.95K | 383.38K | -302.24K | 188.2K | 69.73K |
| Pretax Income | -5.43M | -4.47M | -4.74M | -5.67M | -4.43M | -3.26M | -4.47M | -8.14M | -3.99M | -4.71M | -4.7M | -7.66M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 183.07K | 70.12K | 549.29K | 141.21K | 100.51K | 504.74K | 10.99K | 1.21K | 19.87K | 14.5K | 21.46K | 26.59K |
| Effective Tax Rate % | -3.37% | -1.57% | -11.6% | -2.49% | -2.27% | -15.47% | -0.25% | -0.01% | -0.5% | -0.31% | -0.46% | -0.35% |
| Net Income | -5.61M | -4.54M | -5.28M | -5.81M | -4.53M | -3.77M | -4.49M | -8.14M | -4.01M | -4.72M | -4.72M | -7.69M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -23.81% | -20.42% | -17.81% | 28.66% | -12.85% | 20.23% | 4.93% | -5.92% | 21.86% | -1.06% | -3.51% | -51.18% |
| Net Income (Continuing) | -5.61M | -4.54M | -5.28M | -5.81M | -4.53M | -3.77M | -4.49M | -8.14M | -4.01M | -4.72M | -4.72M | -7.69M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.13 | -0.11 | -0.15 | -0.19 | -0.16 | -0.14 | -0.17 | -0.42 | -0.22 | -0.29 | -0.37 | -0.62 |
| EPS Growth % | 18.75% | 21.43% | 11.76% | 54.76% | 27.27% | 51.72% | 54.05% | 32.26% | 48.84% | 25.64% | 2.63% | -44.19% |
| EPS (Basic) | -0.13 | -0.11 | -0.15 | -0.19 | -0.16 | -0.14 | -0.17 | -0.42 | -0.22 | -0.29 | -0.37 | -0.62 |
| Diluted Shares Outstanding | 42.23M | 32.97M | 35M | 30.34M | 28.69M | 27.13M | 26.53M | 19.22M | 17.98M | 16.21M | 12.7M | 12.39M |
| Basic Shares Outstanding | 42.23M | 32.97M | 35M | 30.34M | 28.69M | 27.13M | 26.53M | 19.22M | 17.98M | 16.21M | 12.7M | 12.39M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |